Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Muscle relaxant in general anaesthesia; Facilitate endotracheal intubation Age: Adult |
Dose: Intravenous – Initial dose: 80-100 mcg/kg Note: Subsequent doses: 10-20 mcg/kg |
|
Indication: Muscle relaxant in general anaesthesia; Facilitate endotracheal intubation Age: Adult Condition: Initial dose following suxamethonium administration or in patients at high risk |
Dose: Intravenous – 50-60 mcg/kg |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: Not recommended |
Administration
- For IV administration only
- Follow hospital protocol
Side Effect
- Transient hypotension
- bradycardia
- reduced cardiac output
- Anaphylactic reactions and malignant hyperthermia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Cholinesterases, Carbamazepine, Phenytoin, Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone)
|
Actions antagonised
|
|
Lidocaine, Quinidine, Verapamil, Aminoglycosides
|
Enhanced block
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.